AKT1 (E17K) mutation was reported in breast cancer, meningioma, colorectal cancer, lung cancer, bladder, and ovarian cancer in different frequencies [10,11,12,13,24,38,39,40,41,42,43,44,45,46,47,48]. This evidence concerns the gene AKT1 and lung carcinoma.